clutchshake5
About
Genomic mutation account in modern persistent lymphocytic leukemia sufferers before first-line chemoimmunotherapy using FCR and also rituximab servicing (REM).
Genomic mutation account in modern persistent lymphocytic leukemia sufferers before first-line chemoimmunotherapy using FCR and also rituximab servicing (REM).